KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) Depreciation & Amortization - Total (2016 - 2025)

Historic Depreciation & Amortization - Total for National Health Investors (NHI) over the last 17 years, with Q3 2025 value amounting to $20.2 million.

  • National Health Investors' Depreciation & Amortization - Total rose 1377.76% to $20.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.0 million, marking a year-over-year increase of 1158.8%. This contributed to the annual value of $71.4 million for FY2024, which is 210.08% up from last year.
  • As of Q3 2025, National Health Investors' Depreciation & Amortization - Total stood at $20.2 million, which was up 1377.76% from $19.9 million recorded in Q2 2025.
  • National Health Investors' Depreciation & Amortization - Total's 5-year high stood at $20.8 million during Q1 2021, with a 5-year trough of $17.1 million in Q4 2023.
  • For the 5-year period, National Health Investors' Depreciation & Amortization - Total averaged around $18.5 million, with its median value being $17.8 million (2022).
  • Its Depreciation & Amortization - Total has fluctuated over the past 5 years, first tumbled by 1397.04% in 2022, then soared by 1388.22% in 2025.
  • Quarter analysis of 5 years shows National Health Investors' Depreciation & Amortization - Total stood at $19.3 million in 2021, then dropped by 10.34% to $17.3 million in 2022, then fell by 1.11% to $17.1 million in 2023, then increased by 9.17% to $18.7 million in 2024, then rose by 8.22% to $20.2 million in 2025.
  • Its last three reported values are $20.2 million in Q3 2025, $19.9 million for Q2 2025, and $19.2 million during Q1 2025.